Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.
| Brand name | ESOMEPRAZOLE MAGNESIUM |
| Generic name | ESOMEPRAZOLE MAGNESIUM |
| Active ingredient(s) | ESOMEPRAZOLE MAGNESIUM DIHYDRATE |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534 |
| NDC | 68382-849-94 |
| Full product label | Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94 |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | Nationwide -in the USA |
| Quantity | 30,674 30 sachets/carton |
| Recall initiated | 2025-05-13 |
| Report date | 2025-05-28 |
| Recall completed | — |
| Recall number | D-0442-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗